- Global
- United States
- Australia
- United Kingdom
- Canada
- India
- China
- Argentina
- Austria
- Bahrain
- Bangladesh
- Belgium
- Bermuda
- Botswana
- Brazil
- Bulgaria
- Chile
- Colombia
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Egypt
- Estonia
- Finland
- France
- Germany
- Ghana
- Greece
- Hong Kong
- Hungary
- Iceland
- Indonesia
- Ireland
- Israel
- Italy
- Ivory Coast
- Jamaica
- Japan
- Jordan
- Kenya
- Kuwait
- Latvia
- Lithuania
- Luxembourg
- Malawi
- Malaysia
- Malta
- Mauritius
- Mexico
- Morocco
- Namibia
- Netherlands
- New Zealand
- Nigeria
- Norway
- Oman
- Pakistan
- Palestinian Authority
- Peru
- Philippines
- Poland
- Portugal
- Qatar
- Romania
- Russia
- Saudi Arabia
- Serbia
- Singapore
- Slovakia
- Slovenia
- South Africa
- South Korea
- Spain
- Sri Lanka
- Sweden
- Switzerland
- Taiwan
- Tanzania
- Thailand
- Trinidad & Tobago
- Tunisia
- Turkey
- Uganda
- Ukraine
- United Arab Emirates
- Venezuela
- Vietnam
- Zambia
- Zimbabwe
🌎 Switch to Global Market
Pharmaceuticals & Biotech Filipino Community
Our community narratives are driven by numbers and valuation.
Pharmaceuticals & Biotech Filipino Investing Ideas
There are no community narratives available.
Recently Updated Narratives
AL
China-threatening vital rare earth supplier, LYC.
Fair Value: AU$23.15 17.8% undervalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
TI
Rocket Lab: A Growth Story Trading on the Future of Space Economy
Fair Value: US$7.31 859.4% overvalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
VE
Shell PLC (SHEL): The Integrated Energy Arbitrage – Driving Record Buybacks and High-Margin LNG in 2026.
Fair Value: US$92.48 11.0% undervalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Popular Narratives
DA
Is Ubisoft the Market’s Biggest Pricing Error? Why Forensic Value Points to €33 Per Share
Fair Value: €33.8 88.4% undervalued intrinsic discount
10.7k viewsusers have viewed this narrative
65 followersusers have followed this narrative
5 commentsusers have commented on this narrative
28 likesusers have liked this narrative
AN
Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks
Fair Value: US$596 32.2% undervalued intrinsic discount
6.2k viewsusers have viewed this narrative
1300 followersusers have followed this narrative
2 commentsusers have commented on this narrative
10 likesusers have liked this narrative
KA
Nu holdings will continue to disrupt the South American banking market
Fair Value: US$64.3 77.0% undervalued intrinsic discount
5.5k viewsusers have viewed this narrative
47 followersusers have followed this narrative
3 commentsusers have commented on this narrative
27 likesusers have liked this narrative
